Ying Zan
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Biochemistry top 10%
- Phytochemicals and Antioxidant Activities
Papers in
-
- RNA modifications and cancer 6
- Circular RNAs in diseases 4
- Wnt/β-catenin signaling in development and cancer 2
- Mechanisms of cancer metastasis 2
-
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 3
- Cancer, Hypoxia, and Metabolism 3
- Cancer, Lipids, and Metabolism 2
- Co-authors
- Lili Han (3 shared papers)Lijun Jia (2 shared papers)Xiaoran Yin (2 shared papers)Ya Guo (1 shared paper)Shan Huang (1 shared paper)Zhijun Dai (6 shared papers)Lingqin Song (6 shared papers)Xi-Jing Wang (5 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (2 papers)Biological Chemistry (1 paper)Digestive Diseases (1 paper)Cancer Medicine (1 paper)International Journal of Oncology (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Ying Zan
21 papers receiving 632 citations
Peers
Comparison fields: 5 of 85
- Cancer Research 239
- Biochemistry 52
- Geriatrics and Gerontology 26
- Molecular Biology 403
- Toxicology 19
Countries citing papers authored by Ying Zan
This map shows the geographic impact of Ying Zan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Zan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Zan more than expected).
Fields of papers citing papers by Ying Zan
This network shows the impact of papers produced by Ying Zan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Zan. The network helps show where Ying Zan may publish in the future.
Co-authors
The 25 scholars most cited alongside Ying Zan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 235 | |
| 2 | 2015 | 74 | |
| 3 | 2014 | 43 | |
| 4 | 2019 | 39 | |
| 5 | 2018 | 37 | |
| 6 | 2013 | 37 | |
| 7 | 2017 | 36 | |
| 8 | 2019 | 33 | |
| 9 | 2018 | 26 | |
| 10 | MicroRNA-1292-5p inhibits cell growth, migration and invasion of gastric carcinoma by targeting DEK. | 2018 | 15 |
| 11 | 2019 | 14 | |
| 12 | 2015 | 12 | |
| 13 | 2020 | 10 | |
| 14 | 2024 | 10 | |
| 15 | 2008 | 7 | |
| 16 | 2022 | 5 | |
| 17 | 2022 | 2 | |
| 18 | 2023 | 2 | |
| 19 | 2024 | 1 | |
| 20 | 2022 | 1 |
About Ying Zan
Ying Zan is a scholar working on Molecular Biology, Cancer Research, Oncology, Epidemiology and Pharmacology, having authored 21 papers that have together received 640 indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (4 papers), Cancer-related molecular mechanisms research (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Cancer, Lipids, and Metabolism (2 papers) and Mechanisms of cancer metastasis (2 papers). The work is most often cited by research in Cancer Research (239 citations), Biochemistry (52 citations), Geriatrics and Gerontology (26 citations), Molecular Biology (403 citations) and Toxicology (19 citations). Ying Zan has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Lili Han, Lijun Jia, Xiaoran Yin, Ya Guo, Shan Huang, Zhijun Dai, Lingqin Song, Xi-Jing Wang, Huafeng Kang and Di Liu. Their work appears in journals such as Biochemical and Biophysical Research Communications, Biological Chemistry, Digestive Diseases, Cancer Medicine and International Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.